Not available
Quote | Solid Biosciences Inc. (NASDAQ:SLDB)
Last: | $12.96 |
---|---|
Change Percent: | -9.05% |
Open: | $14.82 |
Close: | $14.25 |
High: | $15.05 |
Low: | $12.96 |
Volume: | 260,154 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Solid Biosciences Inc. (NASDAQ:SLDB)
2024-03-28 12:38:28 ET More on Solid Biosciences Solid Biosciences: DMD Treatment Advancement With Next-Generation Capsid Piper Sandler upgrades Solid Biosciences to overweight Solid Biosciences reports Q4 results Seeking Alpha’s Quant Rating on Solid ...
2024-03-27 21:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Solid Biosciences Inc. (NASDAQ:SLDB)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SLDB News Article - Solid Biosciences to Present at Barclays Global Healthcare Confere | whytestocks | investorshangout | 03/07/2023 6:45:47 PM |
!5 = 1 RS. 42 = 6.30. | kzivann | investorshub | 10/31/2022 2:49:59 PM |
whytestocks: $SLDB News Article - SLDB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Me | whytestocks | investorshangout | 09/30/2022 2:10:47 PM |
whytestocks: $SLDB News Article - Solid Biosciences Announces Acquisition of AavantiBio and Concurre | whytestocks | investorshangout | 09/30/2022 1:55:48 PM |
SLDB looking for a run up tomorrow, should | Gizzer211 | investorshub | 03/14/2022 11:00:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Solid Biosciences Inc. Company Name:
SLDB Stock Symbol:
NASDAQ Market:
2024-03-27 21:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CHARLESTOWN, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB), a life sciences company developing precision genet...
CHARLESTOWN, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, and Gabriel Brooks, ...